Skinoren

Land: Armenien

Sprache: Englisch

Quelle: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Wirkstoff:

azelaic acid

Verfügbar ab:

Bayer Healthcare Manufacturing S.r.l.

INN (Internationale Bezeichnung):

azelaic acid

Dosierung:

200mg/g

Darreichungsform:

cream for external use

Verschreibungstyp:

OTC

Fachinformation

1/8
Skinoren cream
Summary of Product Characteristics
SKINOREN CREAM
*
AZELAIC ACID
20 % CREAM
*
This medicinal product is registered / marketed under the following
trade names: Skinoren,
Cutacelan, Azelan, Azalea, Azelex, Finevin.
2/8
Skinoren cream
TABLE OF CONTENTS
1.
NAME OF THE MEDICINAL PRODUCT
........................................................... 4
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION IN TERMS OF
THE ACTIVE SUBSTANCE(S)
..............................................................................
4
3.
PHARMACEUTICAL FORM
.................................................................................
4
4.
CLINICAL PARTICULARS
...................................................................................
4
4.1
INDICATION(S)
...............................................................................................................
4
4.2
DOSAGE AND METHOD OF ADMINISTRATION
.....................................................................
4
4.3
CONTRAINDICATIONS
......................................................................................................
4
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
............................................................... 4
4.5
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION ......... 5
4.6
PREGNANCY AND
LACTATION............................................................................................
5
4.6.1
PREGNANCY
.................................................................................................................
5
4.6.2
LACTATION...................................................................................................................
5
4.7
EFFECTS ON ABILITY TO DRIVE OR USE
MACHINES..............................................................
5
4.8
UNDESIRABLE
EFFECTS.....................................................................................................
5
4.9
OVERDOSE
................................................................................................